Study type: In vivo/preclinical · Status: Citation identity verified

The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuroactive chemical sequence Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat.

Journal of neuroendocrinology · 2003

Study scale: Not reported

Citation only: Open source record

Product or molecular entity relationships

Melanotan II: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Not reported in the reviewed source.

Key findings

Not reported in the reviewed source.

Limitations and uncertainty

Not reported in the reviewed source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.